Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Jardiance (empagliflozin) is frequently confused with GLP-1 medications, but they work through entirely different biological pathways. Jardiance is an SGLT2 inhibitor that removes excess glucose through urine, while GLP-1 drugs like semaglutide signal your brain to reduce hunger and slow digestion. Knowing this difference is essential for selecting the right therapy for your individual health needs.
What Class of Drug Is Jardiance?
Jardiance belongs to the SGLT2 inhibitor family, a class approved primarily for type 2 diabetes management. SGLT2 inhibitors work by blocking a protein in your kidneys that reabsorbs glucose, allowing excess sugar to leave your body through urine instead of staying in your bloodstream. This mechanism lowers blood glucose levels and has shown modest weight loss benefits in clinical trials, typically 2–4 pounds on average. Jardiance also offers cardiovascular protection and can reduce heart failure risk, making it valuable for certain diabetes patients.
Unlike GLP-1 receptor agonists, SGLT2 inhibitors do not directly affect appetite regulation or satiety signals in your brain. The weight loss seen with Jardiance is generally a side effect of blood sugar control and calorie loss through urinary glucose excretion, not active hunger suppression. Many patients seeking significant weight loss outcomes find GLP-1 medications more effective for appetite control and metabolic transformation.
How GLP-1 Drugs Differ From Jardiance
GLP-1 receptor agonists—such as semaglutide—activate natural hormone receptors in your brain that control appetite, satiety, and food intake. When you take semaglutide, it mimics glucagon-like peptide-1, a hormone your gut naturally produces after eating. This activation slows your stomach's emptying, increases feelings of fullness after smaller meals, and reduces cravings for high-calorie foods. Clinical trials show weight loss averaging 15–22% of body weight over 68 weeks, far exceeding the effects of SGLT2 inhibitors alone.
Semaglutide also improves blood sugar control by stimulating insulin release when glucose levels rise, offering dual benefits for metabolic health. The medication works on your central nervous system to fundamentally change how your body experiences hunger and portion control. This neural mechanism explains why many patients report sustained weight loss and improved dietary habits with GLP-1 therapy, even after treatment ends.
Can You Use Jardiance and GLP-1 Together?
Some patients benefit from combined therapy using both an SGLT2 inhibitor like Jardiance and a GLP-1 medication such as semaglutide. Your healthcare provider may recommend this combination if you have type 2 diabetes, significant weight loss goals, and cardiovascular risk factors. The two drug classes work through independent pathways, allowing complementary effects on blood sugar control, kidney health, and weight management. However, combining medications requires careful monitoring by a qualified clinician familiar with both drug classes.
PlexusDx specializes in personalized GLP-1 therapy, including compounded semaglutide injection starting at $149/mo, which may be prescribed alongside your existing Jardiance regimen under physician supervision. The Precision Peptide Genetic Test offered by PlexusDx identifies how your individual genetics influence GLP-1 receptor sensitivity and peptide metabolism, helping your provider optimize single or combined therapies for maximum results.
Choosing Between SGLT2 Inhibitors and GLP-1s for Weight Loss
Your choice between Jardiance and GLP-1 medications depends on your primary health goal, existing conditions, and genetic predisposition to weight loss. If your main objective is significant weight loss with appetite suppression, GLP-1 drugs like semaglutide deliver superior outcomes supported by large randomized trials. If you have heart failure, kidney disease, or type 2 diabetes as your primary concern, an SGLT2 inhibitor may be your first-line option. Many people find that GLP-1 therapy addresses both weight and metabolic issues more comprehensively.
PlexusDx offers multiple GLP-1 formulations to match your lifestyle: compounded semaglutide injection starts at $149/mo, and oral semaglutide begins at $249/mo—both from licensed 503A compounding pharmacies serving all 50 states without insurance requirements. A genetic consultation using the Precision Peptide Genetic Test ($99 add-on after your first month) reveals how variants in GLP1R, GIPR, FTO, and MC4R pathways influence your personal weight loss trajectory, enabling truly precision-guided therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Jardiance the same as a GLP-1 medication?
No. Jardiance is an SGLT2 inhibitor that removes glucose through urine, while GLP-1 drugs like semaglutide activate brain receptors to reduce hunger and slow digestion. They work through completely different mechanisms.
Which medication causes more weight loss: Jardiance or semaglutide?
Semaglutide produces significantly greater weight loss, averaging 15–22% of body weight in clinical trials, compared to 2–4 pounds typically seen with Jardiance. This difference reflects semaglutide's direct appetite-suppressing action on the central nervous system.
Can my doctor prescribe semaglutide alongside my Jardiance?
Yes, some patients benefit from combined therapy under physician supervision. Both medications work independently, allowing complementary metabolic effects. PlexusDx compounded semaglutide injection starts at $149/mo and is available nationwide without insurance.
What are the side effects of GLP-1 drugs compared to SGLT2 inhibitors?
GLP-1 side effects typically include nausea, vomiting, and constipation during dose escalation, which usually fade over time. SGLT2 inhibitors carry infection risks and rare diabetic ketoacidosis. Both classes require medical oversight, and your clinician should monitor your tolerance carefully.
How does the Precision Peptide Genetic Test help with GLP-1 therapy?
PlexusDx's test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide and other peptide therapies. At $99 after your first treatment month, this genetic insight helps optimize your dose and choice of medication for personalized results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Zepbound Work Better Than Compounded Tirzepatide?
Does Ozempic Help People with PCOS?